Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (11-20 of 430) with videos related to

Pageof 43
Sort By:
Medical Hypotheses|November 19, 2020
Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposingStergios A Polyzos, Antonis Goulas
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2019
CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras
Current Obesity Reports|March 8, 2024
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Giovanni Targher
European Journal of Internal Medicine|July 18, 2016
Homocysteine in nonalcoholic steatohepatitis: A replyStergios A Polyzos, Jannis Kountouras
Helicobacter|April 6, 2019
Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapyStergios A Polyzos, Jannis Kountouras
Annals of Hepatology|July 24, 2020
Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras
Endocrine|July 10, 2016
Clinical vertebral fractures following denosumab discontinuationStergios A Polyzos, Evangelos Terpos
Current Vascular Pharmacology|July 12, 2018
Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic PerspectivesVasiliki Venetsanaki, Stergios A Polyzos
Hormones (Athens, Greece)|June 6, 2022
Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancerStergios A Polyzos, Niki Katsiki
Journal of Gastroenterology and Hepatology|December 4, 2024
Vitamin E in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Jannis Kountouras
Pageof 43

Showing results (11-20 of 430) with videos related to

Sort By:
Pageof 43
Medical Hypotheses|November 19, 2020
Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposingStergios A Polyzos, Antonis Goulas
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2019
CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras
Current Obesity Reports|March 8, 2024
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Giovanni Targher
European Journal of Internal Medicine|July 18, 2016
Homocysteine in nonalcoholic steatohepatitis: A replyStergios A Polyzos, Jannis Kountouras
Helicobacter|April 6, 2019
Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapyStergios A Polyzos, Jannis Kountouras
Annals of Hepatology|July 24, 2020
Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras
Endocrine|July 10, 2016
Clinical vertebral fractures following denosumab discontinuationStergios A Polyzos, Evangelos Terpos
Current Vascular Pharmacology|July 12, 2018
Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic PerspectivesVasiliki Venetsanaki, Stergios A Polyzos
Hormones (Athens, Greece)|June 6, 2022
Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancerStergios A Polyzos, Niki Katsiki
Journal of Gastroenterology and Hepatology|December 4, 2024
Vitamin E in Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Jannis Kountouras
Pageof 43